Through 5α-reductase (5AR) in the prostate, testosterone is converted into activated dihydrotestosterone, which then binds to the androgen receptor in prostate cells, inducing transcriptional activation of target genes and apoptosis and proliferative imbalance in prostate cells, leading to BPH [94]. Here, AR is linked to benign prostatic hyperplasia.